Referentielijst

Ahles TA (1999)
Ahles TA, Tope DM, Pinkson B et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage. 1999 Sep;18(3):157-63.
 
Ang SK (2010)
Ang SK, Shoemaker LK, Davis MP. Nausea and vomiting in advanced cancer. Am J Hosp Palliat Care. 2010 May;27(3):219-25.
 
Basch E (2011)
Basch E, Prestrud AA, Hesketh PJ et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011 Nov 1;29(31):4189-98.
 
Bentley A (2001)
Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med. 2001 May;15(3):247-53.
 
Benze G (2012a)
Benze G, Alt-Epping B, Geyer A, Nauck F. Behandlung von Übelkeit und |Erbrechen mit Prokinetica und Neuroleptica bei Palliativpatienten. Schmerz. 2012 Sep;26(5):500-14.
 
Benze G (2012b)
Benze G, Geyer A, Alt-Epping B, Nauck F. Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review. Schmerz. 2012 Sep;26(5):481-99
 
Bilio A (2010)
Bilio A, Morello E, Clarke MJ. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006272
 
Brand RE (1998)
Brand RE, DiBaise JK, Quigley EM et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet. 1998 Dec 19-26;352(9145):1985.
 
Brooksbank MA (2002)
Brooksbank MA, Game PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002 Nov;16(6):520-6.
 
Brown S (1992)
Brown S, North D, Marvel MK et al. Acupressure wrist bands to relieve nausea and vomiting in hospice patients: do they work? Am J Hosp Palliat Care. 1992 Jul-Aug;9(4):26-9.
 
Bruera E (1987)
Bruera E, Catz Z, Hooper R et al. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage. 1987 Winter;2(1):19-21.
 
Bruera ED (1994)
Bruera ED, MacEachern T, Spachynski KA et al. Comparison of the efficicacy, safety, and pharmacokinetics of controlled release and immediate release meteclopramide for the management of chronic nausea in patients with advanced cancer. Cancer. 1994 Dec 15;74(12):3204-11.
 
Bruera E (1995)
Bruera E, Fainsinger R, Spachinsky K et al. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol. 1995 Jun;13(6):1520-7.
 
Bruera E (1996)
Bruera E, Seifert L, Watanabe S et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage. 1996 Mar;11(3):147-53.
 
Bruera E (2000)
Bruera E, Belzile M, Neumann C et al. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage. 2000 Jun;19(6):427-35.

Bruera E (2004)
Bruera E, Moyano JR, Sala R et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2004 Oct;28(4):381-8.
 
Buchanan D (2007)
Buchanan D, Muirhead K. Intractable nausea and vomiting successfully treated with granisetron 5-hydroxytryptamine type 3 receptor antagonists in palliative medicine. Palliat Med. 2007 Dec;21(8):725-6.
 
Cassileth BR (2004)
Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage. 2004 Sep;28(3):244-9.
 
Critchley P (2001)
Critchley P, Plach N, Grantham M et al. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage. 2001 Aug;22(2):631-4.
 
Cole RM (1998)
Cole RM, Robinson F, Harvey L et al. Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. J Pain Symptom Manage. 1994 Jan;9(1):48-50.
 
Currow DC (1997)
Currow DC, Coughlan M, Fardell B et al. Use of ondansetron in palliative medicine. J Pain Symptom Manage. 1997 May;13(5):302-7.
 
Davis MP (2010)
Davis MP, Hallerberg G. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage. 2010 Apr;39(4):756-67
 
Dietz I (2013)
Dietz I, Schmitz A, Lampey I, Schultz C. Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review. BMC Palliat Care. 2013 Jan 19;12:2.
 
Del Piano M (2005)
Del Piano M, Ballarè M, Montino F et al. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc. 2005 Mar;61(3):421-6.
 
Dormann A (2004)
Dormann A, Meisner S, Verin N et al. Self-expanding stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004 Jun;36(6):543-50.
 
Eagle DA (2001)
Eagle DA, Gian V, Lauwers GY, et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant. 2001 Jul;28(1):59-62..
 
Eisenchlas JH (2005)
Eisenchlas JH, Garrigue N, Junin M et al. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliat Med. 2005 Jan;19(1):71-5.
 
Ezzo JM (2006)
Ezzo JM, Richardson MA, Vickers A et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. Cochrane Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002285.
 
Ezzone S (1998)
Ezzone S, Baker C, Rosselet R et al. Music as an adjunct to antiemetic therapy. Oncol Nurs Forum. 1998 Oct;25(9):1551-6.
 
Gan TJ (2003)
Gan TJ, Meyer T, Apfel CC et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 2003 Jul;97(1):62-71, table of contents.
 
Gemlo B (1986)
Gemlo B, Rayner AA, Lewis B et al. Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg. 1986 Jul;152(1):100-4.
 
Gilligan NP (2005)
Gilligan NP. The palliation of nausea in hospice and palliative care patients with essential oils of Pimpinella anisum (aniseed), Foeniculum vulgare var. dulcec (sweet fennel), Anthemis nobilis (Roman chamomile) and Mentha x piperita (peppermint). The International Journal of Aromatherapy 2005; 15: 163-167.

Glare P (2004)
Glare P, Pereira G, Kristjanson LJ, et al. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.  Support Care Cancer. 2004 Jun;12(6):432-40.
 
Glare PA (2008)
Glare PA, Dunwoodie D, Clark K, et al. Treatment of nausea and vomiting in terminally ill cancer patient. Drugs. 2008;68(18):2575-90.
 
Glare P (2011)
Glare P, Miller J, Nikola T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging. 2011;6:243-59..

Grealish L (2000)
Grealish L, Lomasney A, Whiteman B. Foot Massage. A nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs. 2000 Jun;23(3):237-43.
 
Grunberg SM (2005)
Grunberg SM, Osoba D, Hesketh PJ, et al. Evaluation of new antiemetic agents and definition of antineoplastic emetogenicity – an update. Support Care Cancer. 2005 Feb;13(2):80-4.
 
Gupta M (2013)
Gupta M, LeGrand S, Walsh D, Lagman R. Nausea and vomiting in advanced cancer - "The Cleveland clinical protocol". J Support Oncol. 2013 Mar;11(1):8-13.
 
Hardy F (1990)
Hardy F, Warrington PS, MacPherson JS, et al. A pharmacokinetic study of high-dose metoclopramide suppositories. J Clin Pharm Ther. 1990 Feb;15(1):21-4.
 
Hardy JR (2001)
Hardy JR, Rees E, Ling J et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 2001 Jan;15(1):3-8.
 
Hardy J (2002)
Hardy J, Daly S, McQuade B et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer. 2002 Apr;10(3):231-6.
 
Hardy JR (2010)
Hardy JR, O'Shea A, White C, Gilshenan K, Welch L, Douglas C. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage. 2010 Jul;40(1):111-6.
 
Harris DG (2010)
Harris DG. Nausea and vomiting in advanced cancer. Br Med Bull 2010; 96: 175-85.
 
Heest van FB (2003)
Heest van FB, Meyboom-de Jong B, Otter R. Consultatieve palliatieve zorg bij misselijkheid en braken in de thuissituatie. Ned Tijdschr Geneeskd. 2003 Jul 5;147(27):1297-300.
 
Herrstedt J (2008)
Herrstedt J, Roila F. Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. Ann Oncol. 2008 May;19 Suppl 2:ii110-2.
 
Hosono S (2007)
Hosono S, Ohtani H, Arimoto Y et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol. 2007 Apr;42(4):283-90
 
Ison PJ (1986)
Ison PJ, Peroutka SJ. Neurotransmitter receptor binding studies predict antiemetic efficacy and side effects. Cancer Treat Rep. 1986 May;70(5):637-41
 
Jackson WC (2003)
Jackson WC, Tavernier L. Olanzapine for intractable nausea in palliative care patients. J Palliat Med. 2003 Apr;6(2):251-5.
 
Jeurnink SM (2007)
Jeurnink SM, Steyerberg EW, Eijck van CH et al. Gastrojejunostomie versus endoscopische stentplaatsing als palliatieve behandeling bij een maligne vernauwing van het duodenum: overzicht van voor- en nadelen op basis van een literatuurstudie. Ned Tijdschr Geneeskd. 2007 Mar 3;151(9):536-42.
 
Johnsson E (2004)
Johnsson E, Thune A, Liedman B. Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg. 2004 Aug;28(8):812-7.
 
Kendall BJ (1997)
Kendall BJ, Chakravarti A, Kendall E, et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. Aliment Pharmacol Ther. 1997 Apr;11(2):381-5.
 
Kennett A (2005)
Kennett A, Hardy J, Shah S et al. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2005 Sep;13(9):715-21. Epub 2005 Feb 8.
 
Khoo D (1994)
Khoo D, Hall E, Motson R, et al. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer. 1994;30A(1):28-30.
 
Kumar G (2008)
Kumar G, Hayes KA, Clark R. Efficacy of a scheduled IV cocktail of antiemetics for the palliation of nausea and vomiting in a hospice population. Am J Hosp Palliat Care. 2008 Jun-Jul;25(3):184-9.
 
LEVV (2007)
Landelijk Expertisecentrum Verpleging & Verzorging (LEVV). Richtlijn misselijkheid en braken bij patiënten met kanker in de palliatieve fase. Utrecht, 2007. Ook in te zien en te downloaden via www.pallialine.nl
 
Laval G (2006)
Laval G, Arvieux C, Stefani L, et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage. 2006 Jun;31(6):502-12.
 
Ljutic D (2002)
Ljutic D, Perkovic D, Rumboldt Z et al. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting. Kidney Blood Press Res. 2002;25(1):61-4.
 
Luebbert K (2001)
Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology. 2001 Nov-Dec;10(6):490-502.
 
Macleod AD (2000)
Macleod AD. Ondansetron in multiple sclerosis. J Pain Symptom Manage. 2000 Nov;20(5):388-91.
 
Mangili G (2005)
Mangili G, Aletti G, Frigerio L, et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):830-5.
 
Mangili G (1996)
Mangili G, Franchi M, Mariani A, et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol. 1996 Jun;61(3):345-8.
 
Massacesi C (2006)
Massacesi C, Galeazzi G. Sustained release octreotide may have a role in the treatment of malignant bowel obstruction. Palliat Med. 2006 Oct;20(7):715-6.
 
Matulonis UA (2005)
Matulonis UA, Seiden MV, Roche M et al. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage. 2005 Dec;30(6):563-9.
 
McNamara P (2000)
McNamara P. Paracentesis – an effective method of symptom control in the palliative care setting? Palliat Med. 2000 Jan;14(1):62-4.
 
McNicol E (2003)
McNicol E, Horowicz-Mehler N, Fisk RA et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003 Jun;4(5):231-56.
 
Mehta S (2006)
Mehta S, Hindmarsh A, Cheong E et al. Prospective randomized trial of laparascopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006 Feb;20(2):239-42
 
Mercadante S (2007)
Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage. 2007 Feb;33(2):217-23.
 
Mercadante S (2000)
Mercadante S, Ripamonti C, Casuccio A et al. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer. 2000 May;8(3):188-91.
 
Mittal A (2004)
Mittal A, Windsor J, Woodfield J, et al. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg. 2004 Feb;91(2):205-9.
 
Mystakidou K (1997)
Mystakidou K, Befon S, Trifyllis J et al. Tropisetron versus metoclopramide in the control of emesis in far-advanced cancer. Oncologist. 1997;2(5):319-23.
 
Mystakidou K (1998)
Mystakidou K, Befon S, Liossi C, et al. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer. 1998 Sep 15;83(6):1214-23. (Mystakidou 1998a).
 
Mystakidou K (1998)
Mystakidou K, Befon S, Liossi C et al. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting in patients with advanced cancer. J Pain Symptom Manage. 1998 Mar;15(3):176-84. (Mystakidou 1998b).
 
Mystakidou K (2000)
Mystakidou K, Tsilika E, Kalaidopoulou O et al. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer Res. 2002 Mar-Apr;22(2B):1187-92.
 
Porcel JM (1998)
Porcel JM, Salud A, Porta J et al. Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients. J Pain Symptom Manage. 1998 May;15(5):265-6.
 
Nystrom E (2008)
Nystrom E, Ridderstrom G, Leffler AS. Manual acupuncture as an adjunctive treatment of nausea in patients with cancer in palliative care – a prospective, observational pilot study. Acupunct Med. 2008 Mar;26(1):27-32.
 
Otten MH (2013)
Otten MH. Domperidon. UIt de handel of vrij verkrijbaar? Ned Tijdschr Geneeskd. 2013;157(45):A6950.
 
Pan CX (2000)
Pan CX, Morrison RS, Ness J et al. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage. 2000 Nov;20(5):374-87.
 
Passik SD (2002)
Passik SD, Lundberg J, Kirsh KL et al. A pilot exploration of the antiemetic activity of olanzepine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage. 2002 Jun;23(6):526-32.
 
Pereira J (1996)
Pereira J, Bruera E. Succesful management of intractable nausea with ondansetron: a case study. J Palliat Care. 1996 Summer;12(2):47-50. 
 
Perkins P (2008)
Perkins P, Vowler SL. Does acupressure help reduce nausea and vomiting in palliative care patients? Pilot study. Palliat Med. 2008 Mar;22(2):193-4.
 
Perkins P (2009)
Perkins P, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006271
 
Peroutka SJ (1982)
Peroutka SJ, Snyder SH. Antiemetics: neurotransmitter receptor binding predicts therapeutic actions. Lancet. 1982 Mar 20;1(8273):658-9.
 
Porreca F (2009)
Porreca F, Ossipov MH. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med. 2009 May-Jun;10(4):654-62.
 
Pothuri B (2005)
Pothuri B, Montemarano M, Gerardi M, et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol. 2005 Feb;96(2):330-4.
 
Quigley EM (2001)
Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology. 2001 Jan;120(1):263-86.
 
Ramirez B (1994)
Ramirez B, Eaker EY, Drane WE, et al. Erythromycine enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy. Dig Dis Sci. 1994 Nov;39(11):2295-300.
 
Reddymasu SC (2007)
Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007 Sep;102(9):2036-45.
 
Rhodes VA (2001)
Rhodes VA, McDaniel RW. Nausea, vomiting, and retching: complex problems in palliative care. CA Cancer J Clin. 2001 Jul-Aug;51(4):232-48; quiz 249-52.
 
Richards RD (1993)
Richards RD, Davenport K , McCallum RW . The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol. 1993 Feb;88(2):203-7.
 
Ripamonti C (2000)
Ripamonti C, Mercadante S, Groff L, et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage. 2000 Jan;19(1):23-34.
 
Ripamonti CI (2008)
Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008 May;44(8):1105-15.
 
Roila F (2004)
Roila F, Hesketh PJ, Herrstedt J. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol. 2006 Jan;17(1):20-8.
 
Saxby C (2007)
Saxby C, Ackroyd R, Callin S et al. How should we measure emesis in palliative care? Palliat Med. 2007 Jul;21(5):369-83.
 
Shima Y (2008)
Shima Y, Ohtsu A, Shirao K, et al. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Jpn J Clin Oncol. 2008 May;38(5):354-9.
 
Siddiqui A (2007)
Siddiqui A, Spechler SJ, Huerta S. Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis. Dig Dis Sci. 2007 Jan;52(1):276-81.
 
Srivastava M (2003)
Srivastava M, Brito-Dellan N, Davis MP, et al. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.  J Pain Symptom Manage. 2003 Jun;25(6):578-82.
 
Standley JM (1992)
Standley JM. Clinical applications of music and chemotherapy: the effects on nausea and emesis. Music Therapy Perspectives 1992; 10: 27-35.
 
Stephenson J (2006)
Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2006 Apr;14(4):348-53.
 
Sturm A (1999)
Sturm A, Holtman G, Goebell H, Gerken G. Prokinetics in patients with gastroparesis: a systemic analysis. Digestion. 1999 Sep-Oct;60(5):422-7.
 
Tack J (1992)
Tack J, Janssens J, Vantrappen G, et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992;103:72-9.
 
Van Roeden SE (2013)
Van Roeden SE, Belle-van Meerkerk G, van Tuyl SAC, et al. Domperidon en het risico op acute hartdood. Ned Tijdschr Geneeskd. 2013;157(45):A6770.
 
Vickers AJ (2001)
Vickers AJ, Cassileth BR. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol. 2001 Apr;2(4):226-32.
 
Weschules DJ (2006)
Weschules DJ, Maxwell T, Reifsnyder J, Knowlton CH. Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? Am J Hosp Palliat Care. 2006 Mar-Apr;23(2):135-49.
 
RoilWilson J (2002)
RoilWilson J, Plourde JY, Marshall D et al. Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. J Palliat Care. 2002 Summer;18(2):84-91.

Wood GJ (2007)
Wood GJ, Shega JW, Lynch B, et al. Management of intractable nausea and vomiting in patients at the end of life: “I was feeling nauseous all of the time…nothing was working”. JAMA 2007; 298: 1196-1207.
 
Wright LD (2005)
Wright LD. The use of motion sickness bands to control nausea and vomiting in a group of hospice patients. Am J Hosp Palliat Care. 2005 Jan-Feb;22(1):49-53.

Klinkenberg M (2004)
Klinkenberg M, Willems DL, van der Wal G, Deeg DJ. Symptom burden in the last week of life. J Pain Symptom Manage. 2004 Jan;27(1):5-13.

Licup N 2010 (2010)
Licup N. Olanzapine for nausea and vomiting. Am J Hosp Palliat Care. 2010 Sep;27(6):432-4.
 
Machado Rocha FC (2008)
Machado Rocha FC, Stéfano SC, De Cássia Haiek R, et al. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008 Sep;17(5):431-43. doi: 10.1111/j.1365-2354.2008.00917.x. Epub 2008 Jul 9. Review. PubMed PMID: 18625004.

 
Tramer MR (2001)
Tramèr MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001 Jul 7;323(7303):16-21.

 
Ernst E (2000)
Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials. Br J Anaesth. 2000 Mar;84(3):367-71.
 
Lumb (1993)
Lumb AB. Mechanism of antiemetic effect of ginger. Anaesthesia. 1993 Dec;48(12):1118.
 
Quimby EL (2007)
Quimby EL. The use of herbal therapies in pediatric oncology patients: Treating symptoms of cancer and side effects of standard therapies. J Pediatr Oncol Nurs. 2007 Jan-Feb;24(1):35-40.
 
Sharma SS (1997)
Sharma SS, Kochupillai,V, Gupta SK, et al. Reversal of cisplatin-induced delay in gastric emptying in dogs by ginger (Zingiber officinale). J Ethnopharmacol. 1997 Jul;57(2):93-6.
 
Sharma SS (1998)
Sharma SS, Kochupillai,V, Gupta SK, et al. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). J Ethnopharmacol. 1998 Aug;62(1):49-55.
 
Zick SM (2009)
Zick SM, Ruffin MT, Lee J, et al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer. 2009 May;17(5):563-72